Loading…

Ligand- and Subtype-Selective Coupling of HumanAlpha-2 Adrenoceptors to Ca++ elevation in Chinese Hamster Ovary Cells

The agonist profiles for Ca ++ elevations mediated by the human alpha -2 adrenoceptor subtypes alpha -2A, alpha -2B and alpha -2C were compared in the clones of Chinese hamster ovary cells expressing comparable numbers of receptors. No difference was seen between the different clones with respect to...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pharmacology and experimental therapeutics 1998-11, Vol.287 (2), p.667
Main Authors: Jyrki P. Kukkonen, Annika Renvaktar, Ramin Shariatmadari, Karl E. O. Åkerman
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page 667
container_title The Journal of pharmacology and experimental therapeutics
container_volume 287
creator Jyrki P. Kukkonen
Annika Renvaktar
Ramin Shariatmadari
Karl E. O. Åkerman
description The agonist profiles for Ca ++ elevations mediated by the human alpha -2 adrenoceptor subtypes alpha -2A, alpha -2B and alpha -2C were compared in the clones of Chinese hamster ovary cells expressing comparable numbers of receptors. No difference was seen between the different clones with respect to the maximum Ca ++ mobilizations or the concentrations producing half-maximal stimulation in response to noradrenaline. Ca ++ elevations were sensitive to phospholipase C inhibitor U-73122 (1-[6-([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)aminohexyl]-1H-pyrrole-2,5-dione) and pertussis toxin-pretreatment. Although noradrenaline was equally potent and active in all the clones, marked differences in the response to the other agonists were seen. UK14,304 (5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine) was a full agonist (when compared to noradrenaline) for alpha -2A and alpha -2C, d -medetomidine ([+]-[S]-[4-(1-[2,3-dimethylphenyl]ethyl)-1H-imidazole]HCl) was a full agonist for alpha -2B and alpha -2C and oxymetazoline (3-[(4,5-dihydro-1H-imidazol-2-yl-)methyl]-6-[1,1-dimethylethyl]-2,4-dimethylphenol HCl) was a full agonist only for alpha -2B receptors. Clonidine (2-[2,6-dichloroaniline]-2-imidazoline HCl) was a partial agonist in all the cases; almost no response to this ligand was obtained in the alpha -2B-expressing cells. When the Ca ++ responses are compared to the previously published results on cAMP inhibition in Chinese hamster ovary cells, clonidine seems to be significantly less efficacious in elevating Ca ++ than in decreasing cAMP.
format article
fullrecord <record><control><sourceid>highwire</sourceid><recordid>TN_cdi_highwire_pharmacology_287_2_667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>287_2_667</sourcerecordid><originalsourceid>FETCH-highwire_pharmacology_287_2_6673</originalsourceid><addsrcrecordid>eNqNjb1OwzAURi0EKuHnHe7EUllynMRNx8oCZUBiKHt0SW8TI8eObCcob08GHoDlO8s5-m5Yllcy5yIXxS3LhJCSF5Wq7tlDjN9C5GWpih3bHWtRq2OZsfnd9OguHLaB8_yV1on4mSx1ySwE2s-TNa4Hf4VmHtGd7DQgl3C6BHK-oyn5ECF50Ljfw9YtmIx3YBzowTiKBA2OMVGAjwXDCpqsjU_s7oo20vMfH9nL2-unbvhg-uHHBGq3lzBi563v11bWh1a2Sh2Kf4u_QeJRGw</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ligand- and Subtype-Selective Coupling of HumanAlpha-2 Adrenoceptors to Ca++ elevation in Chinese Hamster Ovary Cells</title><source>Freely Accessible Journals</source><creator>Jyrki P. Kukkonen ; Annika Renvaktar ; Ramin Shariatmadari ; Karl E. O. Åkerman</creator><creatorcontrib>Jyrki P. Kukkonen ; Annika Renvaktar ; Ramin Shariatmadari ; Karl E. O. Åkerman</creatorcontrib><description>The agonist profiles for Ca ++ elevations mediated by the human alpha -2 adrenoceptor subtypes alpha -2A, alpha -2B and alpha -2C were compared in the clones of Chinese hamster ovary cells expressing comparable numbers of receptors. No difference was seen between the different clones with respect to the maximum Ca ++ mobilizations or the concentrations producing half-maximal stimulation in response to noradrenaline. Ca ++ elevations were sensitive to phospholipase C inhibitor U-73122 (1-[6-([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)aminohexyl]-1H-pyrrole-2,5-dione) and pertussis toxin-pretreatment. Although noradrenaline was equally potent and active in all the clones, marked differences in the response to the other agonists were seen. UK14,304 (5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine) was a full agonist (when compared to noradrenaline) for alpha -2A and alpha -2C, d -medetomidine ([+]-[S]-[4-(1-[2,3-dimethylphenyl]ethyl)-1H-imidazole]HCl) was a full agonist for alpha -2B and alpha -2C and oxymetazoline (3-[(4,5-dihydro-1H-imidazol-2-yl-)methyl]-6-[1,1-dimethylethyl]-2,4-dimethylphenol HCl) was a full agonist only for alpha -2B receptors. Clonidine (2-[2,6-dichloroaniline]-2-imidazoline HCl) was a partial agonist in all the cases; almost no response to this ligand was obtained in the alpha -2B-expressing cells. When the Ca ++ responses are compared to the previously published results on cAMP inhibition in Chinese hamster ovary cells, clonidine seems to be significantly less efficacious in elevating Ca ++ than in decreasing cAMP.</description><identifier>ISSN: 0022-3565</identifier><identifier>EISSN: 1521-0103</identifier><identifier>PMID: 9808694</identifier><language>eng</language><publisher>American Society for Pharmacology and Experimental Therapeutics</publisher><ispartof>The Journal of pharmacology and experimental therapeutics, 1998-11, Vol.287 (2), p.667</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Jyrki P. Kukkonen</creatorcontrib><creatorcontrib>Annika Renvaktar</creatorcontrib><creatorcontrib>Ramin Shariatmadari</creatorcontrib><creatorcontrib>Karl E. O. Åkerman</creatorcontrib><title>Ligand- and Subtype-Selective Coupling of HumanAlpha-2 Adrenoceptors to Ca++ elevation in Chinese Hamster Ovary Cells</title><title>The Journal of pharmacology and experimental therapeutics</title><description>The agonist profiles for Ca ++ elevations mediated by the human alpha -2 adrenoceptor subtypes alpha -2A, alpha -2B and alpha -2C were compared in the clones of Chinese hamster ovary cells expressing comparable numbers of receptors. No difference was seen between the different clones with respect to the maximum Ca ++ mobilizations or the concentrations producing half-maximal stimulation in response to noradrenaline. Ca ++ elevations were sensitive to phospholipase C inhibitor U-73122 (1-[6-([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)aminohexyl]-1H-pyrrole-2,5-dione) and pertussis toxin-pretreatment. Although noradrenaline was equally potent and active in all the clones, marked differences in the response to the other agonists were seen. UK14,304 (5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine) was a full agonist (when compared to noradrenaline) for alpha -2A and alpha -2C, d -medetomidine ([+]-[S]-[4-(1-[2,3-dimethylphenyl]ethyl)-1H-imidazole]HCl) was a full agonist for alpha -2B and alpha -2C and oxymetazoline (3-[(4,5-dihydro-1H-imidazol-2-yl-)methyl]-6-[1,1-dimethylethyl]-2,4-dimethylphenol HCl) was a full agonist only for alpha -2B receptors. Clonidine (2-[2,6-dichloroaniline]-2-imidazoline HCl) was a partial agonist in all the cases; almost no response to this ligand was obtained in the alpha -2B-expressing cells. When the Ca ++ responses are compared to the previously published results on cAMP inhibition in Chinese hamster ovary cells, clonidine seems to be significantly less efficacious in elevating Ca ++ than in decreasing cAMP.</description><issn>0022-3565</issn><issn>1521-0103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqNjb1OwzAURi0EKuHnHe7EUllynMRNx8oCZUBiKHt0SW8TI8eObCcob08GHoDlO8s5-m5Yllcy5yIXxS3LhJCSF5Wq7tlDjN9C5GWpih3bHWtRq2OZsfnd9OguHLaB8_yV1on4mSx1ySwE2s-TNa4Hf4VmHtGd7DQgl3C6BHK-oyn5ECF50Ljfw9YtmIx3YBzowTiKBA2OMVGAjwXDCpqsjU_s7oo20vMfH9nL2-unbvhg-uHHBGq3lzBi563v11bWh1a2Sh2Kf4u_QeJRGw</recordid><startdate>19981101</startdate><enddate>19981101</enddate><creator>Jyrki P. Kukkonen</creator><creator>Annika Renvaktar</creator><creator>Ramin Shariatmadari</creator><creator>Karl E. O. Åkerman</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope/></search><sort><creationdate>19981101</creationdate><title>Ligand- and Subtype-Selective Coupling of HumanAlpha-2 Adrenoceptors to Ca++ elevation in Chinese Hamster Ovary Cells</title><author>Jyrki P. Kukkonen ; Annika Renvaktar ; Ramin Shariatmadari ; Karl E. O. Åkerman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-highwire_pharmacology_287_2_6673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jyrki P. Kukkonen</creatorcontrib><creatorcontrib>Annika Renvaktar</creatorcontrib><creatorcontrib>Ramin Shariatmadari</creatorcontrib><creatorcontrib>Karl E. O. Åkerman</creatorcontrib><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jyrki P. Kukkonen</au><au>Annika Renvaktar</au><au>Ramin Shariatmadari</au><au>Karl E. O. Åkerman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ligand- and Subtype-Selective Coupling of HumanAlpha-2 Adrenoceptors to Ca++ elevation in Chinese Hamster Ovary Cells</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><date>1998-11-01</date><risdate>1998</risdate><volume>287</volume><issue>2</issue><spage>667</spage><pages>667-</pages><issn>0022-3565</issn><eissn>1521-0103</eissn><abstract>The agonist profiles for Ca ++ elevations mediated by the human alpha -2 adrenoceptor subtypes alpha -2A, alpha -2B and alpha -2C were compared in the clones of Chinese hamster ovary cells expressing comparable numbers of receptors. No difference was seen between the different clones with respect to the maximum Ca ++ mobilizations or the concentrations producing half-maximal stimulation in response to noradrenaline. Ca ++ elevations were sensitive to phospholipase C inhibitor U-73122 (1-[6-([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)aminohexyl]-1H-pyrrole-2,5-dione) and pertussis toxin-pretreatment. Although noradrenaline was equally potent and active in all the clones, marked differences in the response to the other agonists were seen. UK14,304 (5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine) was a full agonist (when compared to noradrenaline) for alpha -2A and alpha -2C, d -medetomidine ([+]-[S]-[4-(1-[2,3-dimethylphenyl]ethyl)-1H-imidazole]HCl) was a full agonist for alpha -2B and alpha -2C and oxymetazoline (3-[(4,5-dihydro-1H-imidazol-2-yl-)methyl]-6-[1,1-dimethylethyl]-2,4-dimethylphenol HCl) was a full agonist only for alpha -2B receptors. Clonidine (2-[2,6-dichloroaniline]-2-imidazoline HCl) was a partial agonist in all the cases; almost no response to this ligand was obtained in the alpha -2B-expressing cells. When the Ca ++ responses are compared to the previously published results on cAMP inhibition in Chinese hamster ovary cells, clonidine seems to be significantly less efficacious in elevating Ca ++ than in decreasing cAMP.</abstract><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>9808694</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0022-3565
ispartof The Journal of pharmacology and experimental therapeutics, 1998-11, Vol.287 (2), p.667
issn 0022-3565
1521-0103
language eng
recordid cdi_highwire_pharmacology_287_2_667
source Freely Accessible Journals
title Ligand- and Subtype-Selective Coupling of HumanAlpha-2 Adrenoceptors to Ca++ elevation in Chinese Hamster Ovary Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A40%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-highwire&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ligand-%20and%20Subtype-Selective%20Coupling%20of%20HumanAlpha-2%20Adrenoceptors%20to%20Ca++%20elevation%20in%20Chinese%20Hamster%20Ovary%20Cells&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Jyrki%20P.%20Kukkonen&rft.date=1998-11-01&rft.volume=287&rft.issue=2&rft.spage=667&rft.pages=667-&rft.issn=0022-3565&rft.eissn=1521-0103&rft_id=info:doi/&rft_dat=%3Chighwire%3E287_2_667%3C/highwire%3E%3Cgrp_id%3Ecdi_FETCH-highwire_pharmacology_287_2_6673%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/9808694&rfr_iscdi=true